Marshall Wace, LLP Xencor Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $599,195 - $776,453	36,249 New	36,249 $769,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $757,408 - $942,865	30,553 New	30,553 $795,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $4.07 Million - $5.98 Million	-206,292 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $5.5 Million - $8.59 Million	206,292 New	206,292 $5.5 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $4.24 Million - $5.47 Million	-126,015 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $2.85 Million - $3.32 Million	92,910 Added 280.65%	126,015 $4.12 Million
Q2 2021 Aug 13, 2021	BUY	$34.33 - $44.68 $330,872 - $430,625	9,638 Added 41.07%	33,105 $1.14 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $957,688 - $1.26 Million	23,467 New	23,467 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $3.41 Million - $4.88 Million	-113,451 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $2.76 Million - $3.32 Million	99,283 Added 700.76%	113,451 $3.68 Million
Q1 2020 May 15, 2020	SELL	$20.69 - $37.79 $1.19 Million - $2.17 Million	-57,503 Reduced 80.23%	14,168 $423,000
Q4 2019 Feb 14, 2020	BUY	$32.75 - $41.43 $1.08 Million - $1.37 Million	33,017 Added 85.42%	71,671 $2.47 Million
Q3 2019 Nov 14, 2019	SELL	$33.73 - $46.27 $11 Million - $15.1 Million	-325,637 Reduced 89.39%	38,654 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$29.6 - $40.93 $10 Million - $13.9 Million	338,639 Added 1320.13%	364,291 $14.9 Million
Q1 2019 May 14, 2019	BUY	$27.85 - $38.09 $714,408 - $977,084	25,652 New	25,652 $797,000

Others Institutions Holding XNCR

# of Institutions

214

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

Black Rock Inc. New York, NY

11.1M
Shares

$203 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.14M
Shares

$167 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

7.6M
Shares

$139 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$97.4 Million
4.65% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.93M
Shares

$71.8 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account